跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Epsytam - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Epsytam
Approved
STANDARD
Epsytam
Lloyd Laboratories,Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1f9f4bdf2046ddd5
Company
Lloyd Laboratories,Inc.
Type
Standard
Approval Details
Approval Id
1f9f4bdf2046ddd5
Drug Approval Philippines Name
Epsytam
Product Name
Epsytam
Registration Number
DR-XY43112
Brand Name
Epsytam
Generic Name
Levetiracetam
Dosage Form
Film-Coated Tablet
Dosage Strength
500 mg
Manufacturer
Lloyd Laboratories,Inc.
Trader
Aldril Pharmaceuticals, Inc.
Issuance Date
28 August 2023
Expiry Date
19 December 2028
Pharmacologic Category
Anti-epileptic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1f9f4bdf2046ddd5
Type
Standard
Back to Philippines FDA Approvals